Nu Skin Enterprises (NUS) Scheduled to Post Quarterly Earnings on Wednesday

Nu Skin Enterprises (NYSE:NUSGet Rating) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, May 4th. Analysts expect the company to announce earnings of $0.73 per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

Nu Skin Enterprises (NYSE:NUSGet Rating) last posted its earnings results on Wednesday, February 16th. The company reported $1.11 EPS for the quarter, beating the Zacks’ consensus estimate of $0.95 by $0.16. Nu Skin Enterprises had a net margin of 5.46% and a return on equity of 23.39%. The company had revenue of $673.44 million during the quarter, compared to analysts’ expectations of $655.93 million. During the same quarter in the prior year, the company posted $1.40 earnings per share. Nu Skin Enterprises’s revenue for the quarter was down 10.0% compared to the same quarter last year. On average, analysts expect Nu Skin Enterprises to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

NYSE:NUS opened at $42.54 on Wednesday. Nu Skin Enterprises has a 52 week low of $39.40 and a 52 week high of $62.70. The firm has a 50 day moving average of $48.01 and a 200 day moving average of $47.53. The company has a quick ratio of 0.89, a current ratio of 1.65 and a debt-to-equity ratio of 0.29. The stock has a market capitalization of $2.12 billion, a price-to-earnings ratio of 14.93 and a beta of 1.25.

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 9th. Investors of record on Monday, February 28th were given a dividend of $0.385 per share. This is a boost from Nu Skin Enterprises’s previous quarterly dividend of $0.38. The ex-dividend date was Friday, February 25th. This represents a $1.54 dividend on an annualized basis and a yield of 3.62%. Nu Skin Enterprises’s dividend payout ratio is presently 54.04%.

In related news, Director Andrew D. Lipman sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 22nd. The stock was sold at an average price of $53.27, for a total value of $53,270.00. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Ryan S. Napierski sold 25,000 shares of the company’s stock in a transaction that occurred on Friday, February 25th. The shares were sold at an average price of $47.40, for a total value of $1,185,000.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 28,000 shares of company stock worth $1,333,390. 4.00% of the stock is owned by insiders.

Large investors have recently bought and sold shares of the company. Janus Henderson Group PLC purchased a new stake in Nu Skin Enterprises during the third quarter worth $208,000. Schonfeld Strategic Advisors LLC purchased a new position in Nu Skin Enterprises in the fourth quarter valued at $455,000. Allstate Corp increased its holdings in Nu Skin Enterprises by 12.4% in the fourth quarter. Allstate Corp now owns 15,684 shares of the company’s stock valued at $796,000 after buying an additional 1,733 shares in the last quarter. Vident Investment Advisory LLC increased its holdings in Nu Skin Enterprises by 4.4% in the fourth quarter. Vident Investment Advisory LLC now owns 33,578 shares of the company’s stock valued at $1,703,000 after buying an additional 1,401 shares in the last quarter. Finally, UBS Group AG increased its holdings in Nu Skin Enterprises by 13.3% in the third quarter. UBS Group AG now owns 42,922 shares of the company’s stock valued at $1,737,000 after buying an additional 5,040 shares in the last quarter. 80.57% of the stock is owned by hedge funds and other institutional investors.

NUS has been the subject of a number of analyst reports. TheStreet cut shares of Nu Skin Enterprises from a “b” rating to a “c+” rating in a research report on Friday, February 18th. StockNews.com initiated coverage on shares of Nu Skin Enterprises in a research note on Thursday, March 31st. They issued a “hold” rating for the company. DA Davidson lifted their target price on shares of Nu Skin Enterprises from $47.00 to $50.00 and gave the stock a “neutral” rating in a research note on Thursday, February 17th. Zacks Investment Research upgraded shares of Nu Skin Enterprises from a “hold” rating to a “strong-buy” rating and set a $57.00 target price for the company in a research note on Tuesday, March 29th. Finally, Jefferies Financial Group lifted their target price on shares of Nu Skin Enterprises from $61.00 to $75.00 in a research note on Thursday, February 17th. Four research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Nu Skin Enterprises presently has an average rating of “Buy” and a consensus target price of $61.17.

About Nu Skin Enterprises (Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.

Featured Stories

Earnings History for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.